Site icon fundsforNGOs

The Global Fund Invites Application under Tuberculosis: TB/MDR-TB Interventions among Afghan Refugees, in Afghanistan, Iran and Pakistan

The Global Fund is calling for proposals from qualified organizations to provide programming for the strategic priority area “Finding Missing TB Cases” under the Multicountry catalytic funding modality for the 2017-2019 Allocation Period. The last date of submission of application is April 30, 2018. Applicants will be notified of the outcomes of the review by the Global Fund Secretariat and Technical Review Panel (TRP). The successful Applicant or Applicants will then, with the proposed implementing entity and the support of the Global Fund Secretariat, proceed to grant-making.

Of the amount made available for this priority area, this RFP refers to the US$ 5,000,000 made available under Multicountry priority area Tuberculosis: TB/MDRTB interventions among Afghan refugees, returnees and mobile populations in Afghanistan, Iran and Pakistan. The maximum duration of each grant shall be three years from the grant implementation start date. The grant is expected to start on 1 January 2019.

Eligibility Requirement:

The grant will focus on creating a catalytic effect for increased impact by:
a) Strengthening collaboration, information sharing and diagnosis/treatment service referrals between health services reaching Afghan refugees, returnees and migrants and the respective national TB control programs (NTPs) in the host countries, with the aim of finding and treating TB cases among mobile Afghan populations.
b) Strengthening cross-border collaboration, information sharing and referrals among NTPs in the three countries, to ensure effective collaboration between three countries and to ensure treatment is not disrupted for patients relocating from one country to another.
c) Strengthening the capacity of the national TB control program in Afghanistan to effectively diagnose and treat TB cases amongst returnees.

The burden of tuberculosis (TB) in Afghan returnee populations (refugees and undocumented persons) is reported to be three times higher than in the general Afghan population. Limited access of Afghan refugees, returnees and other migrant populations to TB and multidrug resistant tuberculosis (MDR-TB) prevention, diagnosis and treatment services in the countries of residence is a consequence of both a lack of service provision in areas where Afghan settlement is prevalent in neighboring countries and upon their return to Afghanistan. This is further reinforced by the socio-economic status of returnees and their resultant poor living standards.

For further information on Eligibility, please visit: The Global Fund

Exit mobile version